NCT03158506View on ClinicalTrials.gov

Human Mass Balance Study of HMS5552 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

April 6, 2017

Study Completion Date

April 6, 2017

Conditions
Healthy Subject
Interventions
DRUG

HMS5552

\[14C\]-labelled HMS5552

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT03158506 - Human Mass Balance Study of HMS5552 in Healthy Subjects | Biotech Hunter | Biotech Hunter